HilleVax, Inc.
NASDAQ Global SelectTotal Valuation
HilleVax, Inc. carries a market capitalization of 104.76M, placing it among publicly traded companies globally. Its enterprise value stands at -36.97M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 104.76M |
| Enterprise Value | -36.97M |
Share Statistics
HilleVax, Inc. currently has 50.13M shares outstanding.
| Shares Outstanding | 50.13M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.18 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | -1.72 |
| P/OCF Ratio | -1.66 |
Financial Position
HilleVax, Inc. maintains a current ratio of 26.39, meaning it holds 26.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 15.93, indicating elevated leverage, while an interest coverage ratio of -26.81 demonstrates limited ability to service its debt obligations.
| Current Ratio | 26.39 |
| Quick Ratio | 25.96 |
| Debt / Equity | 15.93 |
| Debt / EBITDA | -0.47 |
| Interest Coverage | -26.81 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -31.47 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
HilleVax, Inc.'s stock has gained approximately 11.76471% over the past 52 weeks. The 50-day moving average sits at 2.09, while the 200-day moving average is 1.92.
| Beta (5Y) | N/A |
| 52-Week Price Change | 11.76471% |
| 50-Day Moving Average | 2.09 |
| 200-Day Moving Average | 1.92 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -49.68M, while operating income came in at -52.35M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -52.35M |
| Pretax Income | -71.10M |
| Net Income | -71.10M |
| EBITDA | -49.68M |
| EBIT | -52.35M |
| Earnings Per Share (EPS) | -1.43 |
Balance Sheet
HilleVax, Inc. holds 159.55M in cash and equivalents against 23.54M in total debt, resulting in a net debt position of -58.68M. Total book value stands at -547.15M, with working capital of 156.09M providing operational flexibility.
| Cash & Cash Equivalents | 159.55M |
| Total Debt | 23.54M |
| Net Debt | -58.68M |
| Equity (Book Value) | -547.15M |
| Book Value Per Share | -10.99 |
| Working Capital | 156.09M |
Cash Flow
HilleVax, Inc. produced -59.52M in operating cash flow over the past twelve months. After subtracting -1.82M in capital expenditures, free cash flow totaled -61.34M - equivalent to -1.23 per share.
| Operating Cash Flow | -59.52M |
| Capital Expenditures | -1.82M |
| Free Cash Flow | -61.34M |
| FCF Per Share | -1.23 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 27.77 |
| FCF Yield | -58.26 |
Scores
HilleVax, Inc. posts an Altman Z-Score of -2.10, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -2.10 |